Baseline Lenacapavir Resistance and Capsid Variability in Bulgaria: A Next-Generation Sequencing Study of Newly Diagnosed HIV-1 Infections
Pathogens · 2026
DOI: 10.3390/pathogens15101011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Ivailo Alexiev und 14 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Confirmatory Laboratory of HIV, National Center of Infectious and Parasitic Diseases (NCIPD), 1504 Sofia, Bulgaria. Hauptthemen laut MEDLINE: HIV-1, Drug Resistance, Viral, HIV Infections, Anti-HIV Agents. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by Project No BG16RFPR002-1.014-0017 Center of Competence "Fundamental, translational and clinical investigations on infections and im….
Abstract (Originalsprache)
Lenacapavir, the first approved HIV-1 capsid inhibitor, is now being introduced for both treatment and pre-exposure prophylaxis, yet the capsid-coding region lies outside the pol fragment examined in routine genotypic resistance testing, and baseline data on capsid variability remain scarce, particularly in epidemics dominated by non-B lineages. We applied next-generation sequencing of the HIV-1 gag gene to 103 lenacapavir-naive individuals newly diagnosed in Bulgaria between 2023 and 2025. Nine lineages were identified. Subtype B accounted for 46.6% of the sequences, whereas non-B lineages together predominated (53.4%), led by sub-subtype F1 (13.6%) and CRF01_AE (8.7%); a further 10.7% remained unassigned and grouped predominantly with BF1 recombinant references. The distribution of these lineages differed significantly according to the probable route of transmission (p = 0.007). No major lenacapavir resistance-associated mutation was detected (0 of 103; 95% CI 0.0–3.6). Substitutions at position 107 were the only changes observed at a resistance-associated position: T107S in two individuals and a T107T/S mixture in one (2.9% combined). Notably, the two T107S sequences formed a CRF01_AE pair supported by a bootstrap value of 100, indicating that this accessory polymorphism can persist in closely related viruses. All viruses were genotypically predicted to remain susceptible to lenacapavir. These findings establish a molecular baseline for capsid surveillance in Bulgaria, a South-Eastern European country with a genetically diverse HIV-1 epidemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Reference Confirmatory Laboratory of HIV, National Center of Infectious and Parasitic Diseases (NCIPD), 1504 Sofia, Bulgaria.
- National Reference Laboratory of Immunology, NCIPD, 1504 Sofia, Bulgaria.
- University Multi-Profile Hospital for Active Treatment of Infectious and Parasitic Diseases, 1606 Sofia, Bulgaria.
- Department of Infectious Diseases, Parasitology and Tropical Medicine, MU-Plovdiv, 4002 Plovdiv, Bulgaria.
- Clinic of Infectious Diseases, University Hospital "Prof. Dr. G. Stranski", 5800 Pleven, Bulgaria.
- Clinic of Infectious Diseases, University Hospital "Prof. Dr. St. Kirkovich", 6003 Stara Zagora, Bulgaria.
ORCID-Profile: Ivailo Alexiev, Reneta Dimitrova, Lyubomira Grigorova, Radoslava Emilova, Dimitar Strashimirov
Förderung
- This research was funded by Project No BG16RFPR002-1.014-0017 Center of Competence "Fundamental, translational and clinical investigations on infections and im…
Zitieren
APA
Alexiev, I., Partsuneva, A., Dimitrova, R., Kostadinova, A., Gancheva, A., Grigorova, L., Stoyanova, K., Nikolova, M., Emilova, R., Yancheva, N., Strashimirov, D., Baltadzhiev, I., Doychinova, T., Parusheva, P., & Todorova, I. (2026). Baseline Lenacapavir Resistance and Capsid Variability in Bulgaria: A Next-Generation Sequencing Study of Newly Diagnosed HIV-1 Infections. Pathogens. https://doi.org/10.3390/pathogens15101011
Vancouver
Alexiev I, Partsuneva A, Dimitrova R, Kostadinova A, Gancheva A, Grigorova L, et al. Baseline Lenacapavir Resistance and Capsid Variability in Bulgaria: A Next-Generation Sequencing Study of Newly Diagnosed HIV-1 Infections. Pathogens. 2026. doi:10.3390/pathogens15101011
BibTeX
@article{Alexiev2026,
author = {Alexiev, Ivailo and Partsuneva, Aleksandra and Dimitrova, Reneta and Kostadinova, Asya and Gancheva, Anna and Grigorova, Lyubomira and Stoyanova, Kristina and Nikolova, Maria and Emilova, Radoslava and Yancheva, Nina and Strashimirov, Dimitar and Baltadzhiev, Ivan and Doychinova, Tsetsa and Parusheva, Pavlina and Todorova, Ivelina},
title = {Baseline Lenacapavir Resistance and Capsid Variability in Bulgaria: A Next-Generation Sequencing Study of Newly Diagnosed HIV-1 Infections},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15101011}
}
EUVIMED